Company / Capital Expenditures
Solventum Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$379.0M
FY2025
5-year range
$251.0M / $380.0M
FY2022-FY2025
Trend
-0.3%
vs FY2024
Sector context
#30 of 151
Health Care
What the data says
Solventum's capital expenditures of $379M is higher than 80% of companies in the Health Care sector (FY2025). Improved from $290M to $379M over the past 2 years.
Based on SEC 10-K filings.
$379M in FY2025 with a 3-year CAGR of +14.7%. Top quartile in the Health Care sector.
Improved from $290M to $379M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 151This company $379.0M Sector average $271.7M
▼
+39.5% above sector average
Key checks
Key Insights
- 3-year CAGR of +14.7%, indicating consistent growth.
- In FY2025, capital expenditures decreased 0.3% year-over-year.
- Ranks #30 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $379.0M | -0.3% |
| FY2024 | $380.0M | +31.0% |
| FY2023 | $290.0M | +15.5% |
| FY2022 | $251.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026